Spots Global Cancer Trial Database for Phase II of AUY922 in Second-line Gastric Cancer in Combination With Trastuzumab in HER2 Positive Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Phase II of AUY922 in Second-line Gastric Cancer in Combination With Trastuzumab in HER2 Positive Patients
Official Title: An Open-label, Single-arm, Multi-center Phase II Study to Evaluate the Efficacy and Safety of AUY922 in Combination With Trastuzumab Standard Therapy as Second-line Treatment in Patients With HER2-positive Advanced Gastric Cancer
Study ID: NCT01402401
Conditions
Study Description
Brief Summary: This study will assess the safety and efficacy of AUY922, when administered, in combination with trastuzumab in adult patients with HER2+ advanced gastric cancer, who have received trastuzumab plus chemotherapy in the first line.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of California at Los Angeles UCLA LeConte Location, Los Angeles, California, United States
Clinical Research Alliance, Lake Success, New York, United States
University of Texas/MD Anderson Cancer Center UT SC, Houston, Texas, United States
Novartis Investigative Site, Leuven, , Belgium
Novartis Investigative Site, Bordeaux Cedex, , France
Novartis Investigative Site, Nice Cedex 2, , France
Novartis Investigative Site, Reims, , France
Novartis Investigative Site, Mannheim, Baden-Württemberg, Germany
Novartis Investigative Site, Heilbronn, , Germany
Novartis Investigative Site, Modena, MO, Italy
Novartis Investigative Site, Kashiwa, Chiba, Japan
Novartis Investigative Site, Sapporo-city, Hokkaido, Japan
Novartis Investigative Site, Seoul, Korea, Korea, Republic of
Novartis Investigative Site, Seoul, Korea, Korea, Republic of
Novartis Investigative Site, Barcelona, Cataluña, Spain
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
